Cash from Financing (Quarterly) Chart

View Cash from Financing (Quarterly) for NUS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Financing (Quarterly) Chart
Start Trial

Historical Cash from Financing (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 -13.38M
March 31, 2026 -20.40M
December 31, 2025 -18.50M
September 30, 2025 -26.88M
June 30, 2025 9.268M
March 31, 2025 -166.30M
December 31, 2024 -43.63M
September 30, 2024 -28.78M
June 30, 2024 -28.82M
March 31, 2024 -31.96M
December 31, 2023 -20.26M
September 30, 2023 -38.37M
June 30, 2023 67.99M
March 31, 2023 1.38M
December 31, 2022 -50.79M
September 30, 2022 -61.11M
June 30, 2022 46.16M
March 31, 2022 -33.76M
December 31, 2021 -35.92M
September 30, 2021 -80.02M
June 30, 2021 29.39M
March 31, 2021 -18.16M
December 31, 2020 -41.84M
September 30, 2020 -110.79M
June 30, 2020 -69.55M
Date Value
March 31, 2020 -22.98M
December 31, 2019 -25.55M
September 30, 2019 -62.57M
June 30, 2019 -13.70M
March 31, 2019 -52.97M
December 31, 2018 -57.90M
September 30, 2018 -49.82M
June 30, 2018 -38.95M
March 31, 2018 29.96M
December 31, 2017 -65.79M
September 30, 2017 -43.91M
June 30, 2017 -31.41M
March 31, 2017 -18.47M
December 31, 2016 -220.59M
September 30, 2016 -64.57M
June 30, 2016 176.21M
March 31, 2016 -25.76M
December 31, 2015 -78.37M
September 30, 2015 -48.11M
June 30, 2015 -79.50M
March 31, 2015 -29.94M
December 31, 2014 25.35M
September 30, 2014 -33.28M
June 30, 2014 0.605M
March 31, 2014 -33.74M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
Herbalife Ltd. -82.70M
The Estée Lauder Companies, Inc. -30.00M
Joey New York, Inc. --
Merion, Inc. --
Warpaint London Plc --